WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
Deficiency leads to nerve damage (neuropathy), which presents as numbness, tingling, or weakness
Whatever area, surface or equipment you want cleaned, we have equipment to safely and efficiently do the job
The peptide works through cumulative effects on follicle function, not immediate action
This guide provides everything you need for precise AOD-9604 administration
Higher NAD+ availability supports mitochondrial activity, which is responsible for producing most of the bodys cellular energy